Key result
The age-standardized prevalence of obesity among US adults with hypertension increased from 39.6% in 2001 to 55.4% in 2023 (P for trend<0.001).
Why the study?
Changes in obesity prevalence among populations with hypertension remain unclear, and investigating them can inform hypertension treatment and management.
Cross-Sectional
Yes
Absolute Event Rate: 55.4% vs 39.6%
p-value: p=<0.001
The prevalence of obesity among US adults with hypertension increased significantly from 39.6% in 2001 to 55.4% in 2023, highlighting a growing dual burden of cardiovascular risk factors.
Obesity prevalence rose in US adults with hypertension; extends prior trends and supports intensified weight management without yet altering practice.
BACKGROUND: Obesity is a factor contributing to the occurrence of hypertension and a risk factor for adverse outcomes in populations with hypertension. The changes in the prevalence of obesity in populations with hypertension remain unclear. Investigating the changes in the prevalence of obesity in populations with hypertension can provide information for the treatment and management of hypertension. METHODS: The clinical data from adults aged ≥20 years with hypertension were extracted from the National Health and Nutrition Examination Survey 2001 to 2023. The primary outcome was the prevalence of obesity (body mass index≥30 kg/m 2 ). The trend in the prevalence of obesity among American adults with hypertension was evaluated via a trend test. RESULTS: The age-standardized prevalence of obesity among populations with hypertension in America increased from 39.6% in 2001 to 55.4% in 2023 ( P for trend<0.001). This trend was observed in men (35.4%–53.6%; P for trend<0.001) and women (45.6%–57.7%; P for trend<0.001) populations with hypertension. While the prevalence of grade II (35 kg/m 2 ≤body mass index<40 kg/m 2 ) and grade III obesity (body mass index≥40 kg/m 2 ) increased significantly in both sexes, the prevalence of grade I obesity (30 kg/m 2 ≤body mass index<35 kg/m 2 ) increased significantly only in men (23.2%–30.0%; P for trend=0.003) and did not significantly change in women (22.2%–21.7%; P for trend=0.135). CONCLUSIONS: The prevalence of obesity among American adults with hypertension increased from 2001 to 2023. In men, the prevalence of grades I, II, and III obesity increased. Among women, the prevalence of only grades II and III obesity increased.
No takes yet. Share an insight, caveat, or question.
Tu et al. (2025) conducted a cross-sectional in Hypertension. Survey year (2001 to 2023) vs. 2001 was evaluated on Prevalence of obesity (body mass index≥30 kg/m2) (p=<0.001). The age-standardized prevalence of obesity among US adults with hypertension increased from 39.6% in 2001 to 55.4% in 2023 (P for trend<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: